These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9918062)

  • 1. Structure and metabolic fate of triacylglycerol- and phospholipid-rich particles of commercial parenteral fat emulsions.
    Ferezou J; Bach AC
    Nutrition; 1999 Jan; 15(1):44-50. PubMed ID: 9918062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intravenous infusions of commercial fat emulsions (Intralipid 10 or 20%) on rat plasma lipoproteins: phospholipids in excess are the main precursors of lipoprotein-X-like particles.
    Hajri T; Férézou J; Lutton C
    Biochim Biophys Acta; 1990 Nov; 1047(2):121-30. PubMed ID: 2248969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipid-rich particles in commercial parenteral fat emulsions. An overview.
    Bach AC; Férézou J; Frey A
    Prog Lipid Res; 1996; 35(2):133-53. PubMed ID: 8944224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of transfer of apolipoproteins between triacylglycerol-rich particles in lipid emulsions and plasma lipoproteins.
    Iriyama K; Carpentier YA
    Nutrition; 1994; 10(3):252-4. PubMed ID: 7919678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid composition and structure of commercial parenteral emulsions.
    Férézou J; Nguyen TL; Leray C; Hajri T; Frey A; Cabaret Y; Courtieu J; Lutton C; Bach AC
    Biochim Biophys Acta; 1994 Jul; 1213(2):149-58. PubMed ID: 8025125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralipid 10%: physicochemical characterization.
    Férézou J; Gulik A; Domingo N; Milliat F; Dedieu JC; Dunel-Erb S; Chevalier C; Bach AC
    Nutrition; 2001; 17(11-12):930-3. PubMed ID: 11744343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of artificial triacylglycerol particles.
    Olivecrona G; Olivecrona T
    Curr Opin Clin Nutr Metab Care; 1998 Mar; 1(2):143-51. PubMed ID: 10565341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between exogenous fat and plasma/lipoproteins.
    Carpentier YA; Richelle M; Bihain BE; Dahlan W; Haumont D; Deckelbaum RJ
    Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 3():29-32. PubMed ID: 3119486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a medium-chain triacylglycerol/long-chain triacylglycerol fat emulsion containing a reduced ratio of phospholipid to triacylglycerol in pediatric surgical patients.
    Lai HS; Lin WH; Wu HC; Chang KJ; Chen WJ
    Nutrition; 2005; 21(7-8):825-30. PubMed ID: 15975490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of chylomicrons and VLDL with monoacid-rich triacylglycerol and characterization of kinetic parameters in lipoprotein lipase-mediated hydrolysis in chickens.
    Sato K; Takahashi T; Takahashi Y; Shiono H; Katoh N; Akiba Y
    J Nutr; 1999 Jan; 129(1):126-31. PubMed ID: 9915888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic distinctiveness of emulsified lipid particles in the bloodstream and its clinical implications.
    Iriyama K
    Surg Today; 1996; 26(9):673-8. PubMed ID: 8883236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of triglyceride-rich emulsions in rats with protein malnutrition.
    Hirata MH; Garcia PB; Maranhão RC
    J Am Coll Nutr; 1993 Feb; 12(1):47-52. PubMed ID: 8440818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous lipid emulsions: removal mechanisms as compared to chylomicrons.
    Hultin M; Carneheim C; Rosenqvist K; Olivecrona T
    J Lipid Res; 1995 Oct; 36(10):2174-84. PubMed ID: 8576643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of protein-free lipid emulsion models of chylomicrons in rats.
    Redgrave TG; Maranhao RC
    Biochim Biophys Acta; 1985 Jun; 835(1):104-12. PubMed ID: 4005270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion of 10% fish oil in mixed medium-chain triacylglycerol-long-chain triacylglycerol emulsions increases plasma triacylglycerol clearance and induces rapid eicosapentaenoic acid (20:5n-3) incorporation into blood cell phospholipids.
    Simoens CM; Deckelbaum RJ; Massaut JJ; Carpentier YA
    Am J Clin Nutr; 2008 Aug; 88(2):282-8. PubMed ID: 18689362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of liposomal content of lipid emulsions on plasma lipid concentrations in low birth weight infants receiving parenteral nutrition.
    Haumont D; Richelle M; Deckelbaum RJ; Coussaert E; Carpentier YA
    J Pediatr; 1992 Nov; 121(5 Pt 1):759-63. PubMed ID: 1432430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incubation of lipid emulsions with plasma lipoproteins modifies the fluidity of each particle.
    Chanson NF; Lontie JF; Carpentier YA; Motta C
    Lipids; 2001 Aug; 36(8):819-25. PubMed ID: 11592733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of lipoprotein lipase and hepatic lipase on long- and medium-chain triglyceride emulsions used in parenteral nutrition.
    Lutz O; Lave T; Frey A; Meraihi Z; Bach AC
    Metabolism; 1989 Jun; 38(6):507-13. PubMed ID: 2725290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mesophase of parenteral fat emulsion is both substrate and inhibitor of lipoprotein lipase and hepatic lipase.
    Lutz O; Meraïhi Z; Ferezou J; Frey A; Lutton C; Bach AC
    Metabolism; 1990 Dec; 39(12):1225-31. PubMed ID: 2246960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the action of lipoprotein lipase on triacylglycerols and phospholipids when presented in mixed liposomes or in emulsion droplets.
    Rojas C; Olivecrona T; Bengtsson-Olivecrona G
    Eur J Biochem; 1991 Apr; 197(2):315-21. PubMed ID: 2026154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.